Log in

LON:CLIN - Clinigen Group Share Price, Forecast & News

GBX 875
+2.00 (+0.23 %)
(As of 02/23/2020 08:46 AM ET)
Today's Range
865.44
Now: GBX 875
890.50
50-Day Range
873
MA: GBX 941.37
987.50
52-Week Range
777.50
Now: GBX 875
1,069
Volume393,180 shs
Average Volume432,646 shs
Market Capitalization£1.16 billion
P/E Ratio218.75
Dividend Yield0.76%
BetaN/A
Clinigen Group plc operates as a specialty pharmaceutical and services company. The company operates through three segments: Commercial Medicines, Unlicensed Medicines, and Clinical Trial Services. The Commercial Medicines segment acquires and licenses commercial medicines and then revitalises them, as well as provides access to licensed and branded generic medicines in the Africa and Asia Pacific region. Read More…

Industry, Sector and Symbol

Industry Drug Delivery
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1283-495010

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£456.90 million
Cash FlowGBX 62.78 per share
Book ValueGBX 331.10 per share

Profitability

Miscellaneous

Employees849
Market Cap£1.16 billion
Next Earnings Date2/25/2020 (Estimated)
OptionableNot Optionable

Receive CLIN News and Ratings via Email

Sign-up to receive the latest news and ratings for CLIN and its competitors with MarketBeat's FREE daily newsletter.


Clinigen Group (LON:CLIN) Frequently Asked Questions

What is Clinigen Group's stock symbol?

Clinigen Group trades on the London Stock Exchange (LON) under the ticker symbol "CLIN."

How often does Clinigen Group pay dividends? What is the dividend yield for Clinigen Group?

Clinigen Group announced a dividend on Thursday, September 19th. Stockholders of record on Thursday, November 7th will be given a dividend of GBX 4.75 per share on Friday, November 29th. This represents a dividend yield of 0.51%. The ex-dividend date of this dividend is Thursday, November 7th. This is an increase from Clinigen Group's previous dividend of $1.95. The official announcement can be accessed at this link. View Clinigen Group's Dividend History.

How were Clinigen Group's earnings last quarter?

Clinigen Group PLC (LON:CLIN) issued its earnings results on Tuesday, February, 27th. The company reported $21.20 EPS for the quarter, beating the Zacks' consensus estimate of $20.30 by $0.90. The company had revenue of $167.80 million for the quarter. View Clinigen Group's Earnings History.

When is Clinigen Group's next earnings date?

Clinigen Group is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Clinigen Group.

What price target have analysts set for CLIN?

5 Wall Street analysts have issued 1 year price targets for Clinigen Group's stock. Their forecasts range from GBX 1,035 to GBX 1,640. On average, they anticipate Clinigen Group's stock price to reach GBX 1,302 in the next year. This suggests a possible upside of 48.8% from the stock's current price. View Analyst Price Targets for Clinigen Group.

What is the consensus analysts' recommendation for Clinigen Group?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clinigen Group in the last year. There are currently 1 hold rating, 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Clinigen Group.

Has Clinigen Group been receiving favorable news coverage?

Press coverage about CLIN stock has been trending positive this week, according to InfoTrie. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Clinigen Group earned a news impact score of 2.1 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Clinigen Group.

Who are some of Clinigen Group's key competitors?

What other stocks do shareholders of Clinigen Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Clinigen Group investors own include Comerica (CMA), Honda Motor (HMC), Advanced Accelerator Application (AAAP), First Hawaiian (FHB), Landec (LNDC), NII (NIHD), Albemarle (ALB), RTI International Metals (RTI), NetApp (NTAP) and StatPro Group (SOG).

Who are Clinigen Group's key executives?

Clinigen Group's management team includes the folowing people:
  • Mr. Shaun Edward Chilton, CEO & Exec. Director (Age 51)
  • Mr. Nicholas Keher, CFO & Director
  • Ms. Debra Ainge, Chief Operating Officer
  • Matt Parrish, Head of Investor Relations
  • Mr. David Bryant, Director of Corp. Devel.

How do I buy shares of Clinigen Group?

Shares of CLIN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Clinigen Group's stock price today?

One share of CLIN stock can currently be purchased for approximately GBX 875.

How big of a company is Clinigen Group?

Clinigen Group has a market capitalization of £1.16 billion and generates £456.90 million in revenue each year. Clinigen Group employs 849 workers across the globe.View Additional Information About Clinigen Group.

What is Clinigen Group's official website?

The official website for Clinigen Group is http://www.clinigengroup.com/.

How can I contact Clinigen Group?

Clinigen Group's mailing address is Pitcairn House Crown Square, First Avenue, STAFFORDSHIRE, DE14 2WW, United Kingdom. The company can be reached via phone at +44-1283-495010.


MarketBeat Community Rating for Clinigen Group (LON CLIN)

Community Ranking:  3.9 out of 5 (star star star)
Outperform Votes:  402 (Vote Outperform)
Underperform Votes:  112 (Vote Underperform)
Total Votes:  514
MarketBeat's community ratings are surveys of what our community members think about Clinigen Group and other stocks. Vote "Outperform" if you believe CLIN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLIN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel